Not just a tick-the-box exercise: Getting the most out of PRIME designation

The European Medicines Agency’s (EMA) PRIME designation offers significant benefits to sponsors. Perhaps most valuable of these is the opportunity to receive tailored scientific advice and regulatory support from a dedicated rapporteur and scientific coordinator. Yet, in our experience, many companies underutilise this service. Too often, they attend an initial meeting, note the outcomes, begin […]